Skip to main content

pathology microbiology and immunology Archives

Contributors to coronavirus ‘fitness’

Feb. 24, 2015—Understanding the role that host membrane modification plays in coronavirus replication is essential for developing novel approaches to block the viruses that cause SARS and MERS.

Read more


Targeting HIV’s “cap”

Feb. 10, 2015—New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target.

Read more


Vanderbilt-led team studies blood test for prostate cancer

Jan. 5, 2015—Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.

Read more


Target for atherosclerosis therapies

Dec. 17, 2014—A newly identified “atheroprotective” gene is a tool for exploring plaque pathophysiology and may be a good target for therapies to slow atherosclerosis progression.

Read more


Bacterial secretion machinery: 3-D view

Dec. 11, 2014—New structural findings reveal how "gatekeeper" proteins participate in the secretion systems bacteria use to infect host cells.

Read more


Physician-scientist is dream job for Vanderbilt’s Cassat

Dec. 4, 2014—Jim Cassat, M.D., Ph.D., a pediatric infectious disease specialist who joined the Vanderbilt faculty this summer, loves taking care of children with bone infections and doing research to understand the host-pathogen interactions during these invasive infections.

Read more


Twelve Vanderbilt faculty elected AAAS fellows

Nov. 24, 2014—Twelve members of Vanderbilt's faculty have been elected fellows of the American Association for the Advancement of Science for their “scientifically or socially distinguished efforts to advance science or its applications.”

Read more


Host sequesters zinc to control stomach bug

Nov. 21, 2014—Understanding how zinc and the host’s immune response control H. pylori’s cancer-causing potential could suggest new therapeutic strategies to reduce infection and cancer risk.

Read more


Staph ‘gangs’ share nutrients during infection: study

Oct. 16, 2014—Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.

Read more


Lymphocyte study reveals obesity clues

Oct. 16, 2014—Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes.

Read more


A path to sarcoidosis treatment

Sep. 25, 2014—Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.

Read more


Aggressive bone cancers build more blood vessels

Sep. 3, 2014—A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.

Read more


Page 7 of 12« First...4567891011...Last »